Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
AstraZeneca has agreed to divest AstraZeneca Biotech Laboratory, a pilot plant in Södertälje, Sweden, for recombinant proteins and monoclonal antibodies, to Recipharm, a contract development and manufacturing organization. AstraZeneca will hold "a significant minority stake" in the new Recipharm subsidiary, which will supply material for Phase I and II tests of an AstraZeneca drug. AstraZeneca is consolidating all its biotech activities within MedImmune, which it acquired last year.
This article has been sent to the following recipient: